Here are three points:
1. The individual targets of the analysts range between $45 and $98.
2. For the current fiscal quarter, analysts expect the company to deliver $1.02 in earnings per share.
3. Medtronic’s 50-day moving average is $6.15 and its 200-day moving average is $85.23.
More articles on devices:
NuVasive, Bioventus, DFINE & more: 17 key notes
Medtech sells 13 ROSA robots in Q4 2016 — 5 highlights
Dr. Nicole Ehrhart’s preclinical study affirms AlloStem Cellular Bone Allograft effectiveness: 5 key takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
